British American Tobacco (BAT) has announced a major restructuring that will reshape 9,000 roles as part of an artificial intelligence-driven efficiency overhaul. The tobacco giant expects the initiative to deliver £600 million in annual cost savings by 2028, though its US operations will not be included in the changes.
What the Restructuring Involves
The plan, which BAT describes as a transformation of its operating model, will see a significant number of roles redefined, automated, or eliminated as the company leans more heavily on AI and digital tools. The 9,000 role changes represent a substantial portion of BAT’s global workforce, which stood at roughly 52,000 employees at the end of last year. The company has not specified how many jobs will be cut versus retrained or redeployed, but the scale signals a deep reorganisation.
BAT’s move mirrors a broader trend across industries, where companies are increasingly turning to AI to streamline operations, reduce costs, and improve decision-making. For a legacy tobacco firm facing declining smoking rates and tighter regulations, the push toward efficiency is also a bid to free up cash for investment in next-generation products like vaping and heated tobacco.
Why US Operations Are Excluded
Notably, BAT’s US business is exempt from the restructuring. The company’s American operations have been under pressure from regulatory headwinds, including potential bans on menthol cigarettes and stricter rules on flavoured vaping products. By shielding the US unit from the overhaul, BAT may be aiming to avoid disruption in a market that still generates a large share of its revenue, even as it faces an uncertain legal and regulatory landscape.
The exclusion also suggests that the cost savings will come primarily from BAT’s international markets, where the company has more flexibility to reorganise without running into the same level of regulatory complexity.
Regulatory Delays and the Shift to ‘New Categories’
The restructuring comes at a challenging time for BAT’s push into reduced-risk products. The company has been investing heavily in vaping, heated tobacco, and oral nicotine pouches under its “New Categories” strategy, aiming to offset the decline in traditional cigarette sales. However, key product launches have faced delays as regulators in several countries tighten approval processes or impose marketing restrictions.
In the US, the Food and Drug Administration has been slow to authorise new vaping products, while in Europe, proposed bans on certain flavours could limit BAT’s ability to attract adult smokers looking to switch. These headwinds have weighed on investor sentiment, making cost-cutting a more urgent priority to protect margins.
What It Means for Investors
For everyday investors, BAT’s restructuring is a double-edged sword. On one hand, the £600 million in targeted annual savings by 2028 could boost profitability and free up capital for dividends or share buybacks—both of which are important for income-focused shareholders. BAT has long been a high-yield dividend stock, and any move that strengthens its cash flow is generally seen as positive.
On the other hand, the scale of the role changes raises questions about the company’s growth trajectory. Cost-cutting alone cannot replace revenue from declining cigarette sales, and regulatory delays on new products mean the transition to a tobacco-free future remains uncertain. Investors will want to watch whether BAT can accelerate its New Categories revenue growth while executing this restructuring without disrupting its core business.
The exclusion of US operations also means that the savings will come from markets where BAT may have less pricing power or face steeper volume declines. If the company can successfully deploy AI to improve efficiency in those regions, it could set a template for further automation down the line.
Broader Market Context
BAT is not alone in turning to AI for cost savings. Across sectors, from banking to retail, companies are announcing similar initiatives as they look to offset rising labour costs and margin pressure. For investors, this trend underscores the growing importance of AI as a tool for operational efficiency, even in traditional industries like tobacco.
However, the success of such overhauls often depends on execution. Restructuring on this scale can lead to short-term disruption, and there is always a risk that cost cuts go too deep, hurting innovation or customer service. BAT will need to balance its efficiency drive with continued investment in the products that will define its future.
For now, the market will be watching for more details on which roles are affected and how quickly the savings materialise. The company’s next earnings report will likely provide further colour on the timeline and any one-off costs associated with the plan.
